Quality of Life Associated with Treatment of Castration-Resistant Prostate Cancer: A Review of the Literature
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quality of Life Associated with Treatment of Castration-Resistant Prostate Cancer: A Review of the Literature
Authors
Keywords
-
Journal
CANCER INVESTIGATION
Volume 30, Issue 1, Pages 1-12
Publisher
Informa UK Limited
Online
2012-01-12
DOI
10.3109/07357907.2011.629381
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15
- (2010) Colin Johnson et al. EUROPEAN JOURNAL OF CANCER
- Estimates of cancer incidence and mortality in Europe in 2008
- (2010) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Health-related quality of life in pain-free or mildly symptomatic patients with metastatic hormone-resistant prostate cancer following treatment with the specific endothelin A receptor antagonist zibotentan (ZD4054)
- (2010) Nancy Dawson et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
- (2010) Matthew R. Cooperberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Health-related quality of life assessment in prospective trials of systemic cytotoxic chemotherapy for metastatic castration-resistant prostate cancer: which instrument we need?
- (2010) Giuseppe Colloca et al. MEDICAL ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cultural competence in oncology: where do we stand?
- (2009) A. Surbone ANNALS OF ONCOLOGY
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Novel targeted therapeutics for metastatic castration-resistant prostate cancer
- (2009) Emmanuel S. Antonarakis et al. CANCER LETTERS
- Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer
- (2009) P F Mulders et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study
- (2008) D. R. Berthold et al. CLINICAL CANCER RESEARCH
- Issues with the Use of Prostate-Specific Antigen as a Surrogate End Point in Hormone-Resistant Prostate Cancer
- (2008) Don W.W. Newling EUROPEAN UROLOGY SUPPLEMENTS
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started